These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10051005)

  • 21. DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset.
    Jones JS; Amos CI; Pande M; Gu X; Chen J; Campos IM; Wei Q; Rodriguez-Bigas M; Lynch PM; Frazier ML
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):886-91. PubMed ID: 16702365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States.
    Lynch HT; Coronel SM; Okimoto R; Hampel H; Sweet K; Lynch JF; Barrows A; Wijnen J; van der Klift H; Franken P; Wagner A; Fodde R; de la Chapelle A
    JAMA; 2004 Feb; 291(6):718-24. PubMed ID: 14871915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC).
    Geary J; Sasieni P; Houlston R; Izatt L; Eeles R; Payne SJ; Fisher S; Hodgson SV
    Fam Cancer; 2008; 7(2):163-72. PubMed ID: 17939062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A population-based study of hereditary non-polyposis colorectal cancer: evidence of pathologic and genetic heterogeneity.
    Warden G; Harnett D; Green J; Wish T; Woods MO; Green R; Dicks E; Rahman P; Zhai G; Parfrey P
    Clin Genet; 2013 Dec; 84(6):522-30. PubMed ID: 23278430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic counseling in hereditary nonpolyposis colorectal cancer: an extended family with MSH2 mutation.
    Lynch HT; Lemon S; Smyrk T; Franklin B; Karr B; Lynch J; Slominski-Caster S; Murphy P; Connolly C
    Am J Gastroenterol; 1996 Dec; 91(12):2489-93. PubMed ID: 8946971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MSH2 c.1452-1455delAATG is a founder mutation and an important cause of hereditary nonpolyposis colorectal cancer in the southern Chinese population.
    Chan TL; Chan YW; Ho JW; Chan C; Chan AS; Chan E; Lam PW; Tse CW; Lee KC; Lau CW; Gwi E; Leung SY; Yuen ST
    Am J Hum Genet; 2004 May; 74(5):1035-42. PubMed ID: 15042510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Putative common origin of two MLH1 mutations in Italian-Quebec hereditary non-polyposis colorectal cancer families.
    Thiffault I; Foulkes WD; Marcus VA; Farber D; Kasprzak L; MacNamara E; Wong N; Hutter P; Radice P; Bertario L; Chong G
    Clin Genet; 2004 Aug; 66(2):137-43. PubMed ID: 15253764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MSH2 splice site mutation and endometrial cancer.
    Bianchi F; Rosati S; Belvederesi L; Loretelli C; Catalani R; Mandolesi A; Bracci R; Bearzi I; Porfiri E; Cellerino R
    Int J Gynecol Cancer; 2006; 16(3):1419-23. PubMed ID: 16803540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer.
    Vasen HF; Watson P; Mecklin JP; Jass JR; Green JS; Nomizu T; Müller H; Lynch HT
    Anticancer Res; 1994; 14(4B):1675-8. PubMed ID: 7979205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancer.
    de Leon MP; Benatti P; Di Gregorio C; Losi L; Pedroni M; Ponti G; Genuardi M; Viel A; Lucci-Cordisco E; Rossi G; Roncucci L
    Scand J Gastroenterol; 2007 Jun; 42(6):746-53. PubMed ID: 17505997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel MSH2 germline mutation in a Druze HNPCC family.
    Zidan J; Niessen RC; Laitman Y; Rozeveld D; Hofstra RM; Friedman E
    Fam Cancer; 2008; 7(2):135-9. PubMed ID: 17661183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic instability of microsatellites in endometrial carcinoma.
    Risinger JI; Berchuck A; Kohler MF; Watson P; Lynch HT; Boyd J
    Cancer Res; 1993 Nov; 53(21):5100-3. PubMed ID: 8221644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational analysis of hMsh6 in Israeli HNPCC and HNPCC-like families.
    Dovrat S; Figer A; Fidder HH; Neophytou P; Fireman Z; Geva R; Zidan J; Flex D; Meir SB; Friedman E
    Fam Cancer; 2005; 4(4):291-4. PubMed ID: 16341805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence supporting exclusion of the DCC gene and a portion of chromosome 18q as the locus for susceptibility to hereditary nonpolyposis colorectal carcinoma in five kindreds.
    Peltomäki P; Sistonen P; Mecklin JP; Pylkkänen L; Järvinen H; Simons JW; Cho KR; Vogelstein B; de la Chapelle A
    Cancer Res; 1991 Aug; 51(16):4135-40. PubMed ID: 1868434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An effect from anticipation also in hereditary nonpolyposis colorectal cancer families without identified mutations.
    Timshel S; Therkildsen C; Bendahl PO; Bernstein I; Nilbert M
    Cancer Epidemiol; 2009 Oct; 33(3-4):231-4. PubMed ID: 19748845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations.
    Kolodner RD; Hall NR; Lipford J; Kane MF; Rao MR; Morrison P; Wirth L; Finan PJ; Burn J; Chapman P
    Genomics; 1994 Dec; 24(3):516-26. PubMed ID: 7713503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical management.
    Guillem JG; Glogowski E; Moore HG; Nafa K; Markowitz AJ; Shia J; Offit K; Ellis NA
    Ann Surg; 2007 Apr; 245(4):560-5. PubMed ID: 17414604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microsatellite instability and hMSH2 gene mutation in a triple cancer (colon cancer, endometrial cancer, ovarian cancer) patient in hereditary non-polyposis colorectal cancer (HNPCC) kindred.
    Shigemasa K; Yokozaki H; Honda N; Sakata K; Oshita T; Nagai N; Ohama K
    J Obstet Gynaecol Res; 1999 Dec; 25(6):381-6. PubMed ID: 10680334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation.
    Mukherjee B; Rennert G; Ahn J; Dishon S; Lejbkowicz F; Rennert HS; Shiovitz S; Moreno V; Gruber SB
    Gastroenterology; 2011 Jun; 140(7):1919-26. PubMed ID: 21419771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The nonsense mutation MSH2 c.2152C>T shows a founder effect in Portuguese Lynch syndrome families.
    Pinheiro M; Francisco I; Pinto C; Peixoto A; Veiga I; Filipe B; Santos C; Maia S; Silva J; Pinto P; Santos R; Claro I; Lage P; Lopes P; Ferreira S; Rosa I; Fonseca R; Rodrigues P; Henrique R; Chaves P; Pereira AD; Brandão C; Albuquerque C; Teixeira MR
    Genes Chromosomes Cancer; 2019 Sep; 58(9):657-664. PubMed ID: 30968502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.